SCAT1 and breast cancer: Also, significant positive correlations were observed between the expression of SCAT1(CTD-2357A8.3) and AC104653.1 with IC50 of other agents, which may be potential compounds for the treatment of BC by targeting these specific pyroptosis-related lncRNAs.